IL17A and systemic lupus erythematosus: There are also case reports that have evaluated the efficacy of IL-17A inhibitors in SLE patients (27), but further clinical trials are needed to evaluate the long-term efficacy and safety of IL-17 inhibitors in SLE patients, as well as their effects on AS.